Noveris Health Sciences Inc. rose 12.5% on Wednesday, November 4, 2026, on 51,832 shares. No headline about NVRS came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Noveris Health Sciences Inc. (NVRS:CSE) closed at $0.040 on November 9, 2026, down 11.11% on the day. The stock trades 98.7% below its 52-week high of $3.00 and 14.3% above its 52-week low of $0.035. Over the past year, it lost 81.6%. Noveris Health Sciences Inc. is part of the Diversified Industries sector.
In 252 trading sessions since November 6, 2025, NVRS closed higher on 81 days (32%). Its best day was March 16, 2026 (+166.67%) and its worst was May 1, 2026 (-57.67%). The stock moved 10% or more in a single session 69 times. It opened at least 5% above the previous day's high 22 times.
Mydecine Innovations Group is a biotechnology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. The companys world-renowned medical and scientific advisory board is progressing a robust research and development R&D pipeline of psychedelic derived therapeutics novel compounds therapies and controlled drug delivery systems.
Find more stocks like NVRS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.